This was based on the expression of a cell lineage restricted transcription factor PAX8 in both lesions and absence of its expression in either normal urothelium or other urological malignancy including prostatic adenocarcinoma [22]. This evidence concerns the gene PAX8 and prostate adenocarcinoma.